Skip to main content

Table 1 Descriptive statistics of the study cohort stratified by patient group

From: Alzheimer’s pathology is associated with altered cognition, brain volume, and plasma biomarker patterns in traumatic encephalopathy syndrome

 

Repetitive head impact/

traumatic encephalopathy syndrome (RHI/TES)

Healthy controls

MCI/dementia due to AD

Aβ( −)

Aβ( +)

All RHI/TES

  

N

22

11

33

59

62

Age, years

58.5 (12.1)

67.5 (7.6)

61.5 (11.5)

73.0 (6.2)

67.1 (10.2)

Sex, N (%) Female

0 (0)

0 (0)

0 (0)

35 (60)

32 (52)

Education, years

16.6 (1.8)

17.1 (1.4)

16.8 (1.7)

17.3 (2.3)

16.8 (2.6)

Self-reported race, N (%)

    White

18 (82)

10 (91)

28 (85)

53 (90)

52 (84)

    Black

3 (14)

1 (9)

4 (12)

1 (2)

2 (3)

    Asian

0 (0)

0 (0)

0 (0)

2 (3)

6 (10)

    Multiple

1 (5)

0 (0)

1 (3)

3 (5)

2 (3)

APOE genotype, N (%) e4

2 (10)

3 (27)

5 (15)

10 (17)

32 (58)

CDR-sum of boxes

4.0 (3.1)

4.8 (2.6)

4.3 (2.9)

0.0 (0.1)

3.9 (2.3)

CDR + FTLD sum of boxes

5.3 (4.2)

6.1 (3.3)

5.6 (3.9)

0.0 (0.0)

4.4 (2.8)

CDR-global

    0

3 (14)

0 (0)

3 (9)

59 (100)

0 (0)

    0.5

15 (68)

4 (36)

19 (58)

0 (0)

37 (60)

    1.0 + 

4 (18)

7 (64)

11 (33)

0 (0)

25 (40)

Mini-Mental State Exam

26.2 (2.5)

23.5 (7.0)

25.2 (4.7)

29.3 (0.7)

22.9 (5.2)

American football, N (%)

20 (91)

10 (91)

30 (91)

-

-

Years of exposure

12.4 (6.4)

15.4 (3.8)

13.4 (5.8)

-

-

Aβ-PET, Centiloidsa

0.4 (16.7)

23.5 (24.3)

8.1 (22.0)

1.4 (10.3)

91.1 (34.6)

Tau-PET (flortaucipir)

    N

12

6

18

-

43

    Metatemporal ROI SUVR

1.16 (0.09)

1.56 (0.48)

1.31 (0.35)

-

2.01 (0.55)

    SUVR > 1.27, N(%)

1

4

5

-

40

  1. aMean (SD) of Centiloids values reflects only scans performed within 2 years of other study outcomes (cognitive testing, structural imaging, blood draw)